Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gerresheimer AG's gross profit for the
three
months ended in Nov. 2025 was CHF2 Mil. Gerresheimer AG's gross profit for the trailing twelve months (TTM) ended in Nov. 2025 was CHF399 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Gerresheimer AG's gross profit for the
three
months ended in Nov. 2025 was CHF2 Mil. Gerresheimer AG's Revenue for the
three
months ended in Nov. 2025 was CHF594 Mil. Therefore, Gerresheimer AG's Gross Margin % for the quarter that ended in Nov. 2025 was 0.28%.
Gerresheimer AG had a gross margin of 0.28% for the quarter that ended in Nov. 2025 => No sustainable competitive advantage
During the past 13 years, the highestGross Margin % of Gerresheimer AG was 31.39%. The lowest was 18.32%. And the median was 29.90%.
Warning Sign:
Gerresheimer AG gross margin has been in long-term decline. The average rate of decline per year is -7.5%.
Gerresheimer AG (XSWX:GXI) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Gerresheimer AG had a gross margin of 0.28% for the quarter that ended in Nov. 2025 => No sustainable competitive advantage
Gerresheimer AG Gross Profit Related Terms
Gerresheimer AG Gross Profit Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:GXI vs ISRG, BDX, RMD: Gross Profit Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG Gross Profit vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Gross Profit distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF399 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Gerresheimer AG (XSWX:GXI) has a Gross Profit of CHF399 Mil as of Nov. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on Gerresheimer AG and its competitors.
Is Gerresheimer AG's Gross Profit too high?
Gerresheimer AG's current Gross Profit is CHF399 Mil. Overall, Gerresheimer AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Gross Profit compare to ISRG and BDX?
Gerresheimer AG's Gross Profit of CHF399 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Devices & Instruments company?
A good Gross Profit depends on the Medical Devices & Instruments industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Gerresheimer AG and its competitors. Gerresheimer AG's current Gross Profit is CHF399 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Gerresheimer AG (XSWX:GXI) has a current Gross Profit of CHF399 Mil. The stock's GF Value™ is CHF90.02, compared to a current price of CHF25.84 — trading 71.3% below its estimated fair value. The current Gross Profit is CHF399 Mil. Gerresheimer AG's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current Gross Profit is CHF399 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of CHF25.84 is trading 71.3% below its estimated GF Value™ of CHF90.02.
Key valuation signals for XSWX:GXI:
Gross Profit: CHF399 Mil
GF Value™: CHF90.02 vs. price of CHF25.84 (71.3% below fair value)
No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
68GF Score
Get the complete analysis for XSWX:GXI
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GXI has been successfully added to your 
